Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice
- 1 March 1995
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 132 (1) , 16-23
- https://doi.org/10.1016/0014-4886(95)90054-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Nerve growth factor administration protects against experimental diabetic sensory neuropathyBrain Research, 1994
- Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated ratsBrain Research, 1993
- Cisplatin-induced neuropathy in mature rats: Effects of the melanocortin-derived peptide ORG 2766Cancer Chemotherapy and Pharmacology, 1993
- Effects of diabetes on stress-induced analgesia in miceBrain Research, 1992
- Nerve growth factor prevents experimental cisplatin neuropathyAnnals of Neurology, 1992
- Nerve growth factor prevents toxic neuropathy in miceAnnals of Neurology, 1991
- Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathyJournal of Neuroscience Research, 1990
- Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseasesNeurobiology of Aging, 1989
- Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cellsCell and tissue research, 1987
- Axonal dwindling in early experimental diabetes. II. A study of isolated nerve fibresDiabetologia, 1976